Developer docs
API playgroundTry for free, no card

Search company profiles

Medeze Group

Full company profile

uuid000fj48

Namestring
Medeze Group
Legal namestring
MEDEZE Group Public Company Limited (บริษัท เมดีซ กรุ๊ป จำกัด (มหาชน))
Websiteurl
medezegroup.com
Company typeenum
Public
Founded yearint
2010
Short descriptiontext

Medeze Group is a Thailand-based stem cell banking and regenerative medicine company that collects, isolates, cryopreserves, and cultivates mesenchymal, hematopoietic, adipose-derived, and hair follicle stem cells, plus NK cell immune services, serving individual consumers across six Southeast Asian countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBangkok, Thailand
HQ citystring
Bangkok
HQ countrystring
Thailand
HQ regionstring
Asia
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
stem cell banking, regenerative medicine, cord blood banking, NK cell therapy, cryopreservation services
Industry4 codes
PRIMARYHLAAAGAA
Stem Cell–Based Regenerative Therapies
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAABAE
Stem Cell Therapies (MSC/iPSC/HSC-derived)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAABAD
NK Cell Therapies
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
NAICS code2 codes
  • Blood and Organ Banks621991
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Stem Cell Banking Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Stem Cell Banking Services
TypeOne Time License
Description

One-time collection and long-term storage fees for stem cells from cord blood, cord tissue, and adipose tissue. Services are priced as packages starting from 69,000 THB for cord blood banking. Revenue is generated through upfront collection/processing fees combined with ongoing storage fees over the contracted storage period.

medezegroup.com
2NK Cell Services
TypeProfessional Services
Description

NK Cell screening (NK Test) and NK Cell banking with cultivation using the Osaki Method. These services provide immune capacity assessment and highly active NK cell therapy for cancer prevention and immune strengthening.

medezegroup.com
3Hair Follicle Cell Banking
TypeOne Time License
Description

Hair follicle stem cell banking service using proprietary extraction and cryopreservation technology, a niche offering requiring minimal hair follicle extraction compared to traditional methods.

medezegroup.com
4Medical Wellness Services
TypeProfessional Services
Description

Regenerative medicine and anti-aging services including precision medicine consultations, ATMPs Sandbox clinical programs, and longevity-focused healthcare solutions positioned for commercialization by 2026.

medezegroup.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Cord Blood Stem Cell Banking - starting price
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Cord blood stem cell banking starting at 69,000 THB, including collection, processing, isolation via AXP, and cryopreservation with storage certification.

medezegroup.com
2Adipose Tissue Stem Cell Banking - starting price
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Adipose-derived stem cell banking starting at 150,000 THB for general/adult collection (liposuction or tissue removal method), covering the full service from collection through long-term cryopreservation storage.

medezegroup.com
3Adipose Tissue Stem Cell Banking (C-Section) - starting price
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Adipose-derived stem cell banking for C-section delivery starting at 95,000 THB, with collection performed concurrently during the cesarean section procedure.

medezegroup.com
4Cord Tissue Stem Cell Banking
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Placenta and cord tissue stem cell banking available as part of newborn stem cell banking services, with pricing not separately itemized on the website.

medezegroup.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1MEDEZE STEM CELL
Description

Stem cell banking services covering cord blood, cord tissue, adipose tissue, and hair follicle stem cell collection, isolation, and cryopreservation.

medezegroup.com
+2 more records
Core offering1 text field

Medeze Group provides stem cell banking services collecting, isolating, and cryopreserving stem cells from cord blood, cord tissue, adipose tissue, and hair follicles for newborns and adults. The company also offers NK Cell immune screening and Highly Active NK Cell therapy (Osaki Method), as well as hair follicle stem cell banking under the Medeze Hair Renaissance brand. All services operate under ISO 9001:2015 and AABB international accreditation standards from the Thailand headquarters.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Up to 98.7% stem cell isolation accuracy using AXP AutoXpress Platform
+5 more records
Product overview1 text field

MEDEZE Group is a healthcare company offering a portfolio of stem cell banking and regenerative medicine services. The core offering is MEDEZE STEM CELL, which provides multiple stem cell banking services from various sources (cord blood, cord tissue, adipose tissue, and hair follicles) for both newborns and adults. This is complemented by MEDEZE NK for immune cell services (NK Test screening and Osaki Method-based cultivation), and MEDEZE HAIR RENAISSANCE for specialized hair follicle stem cell banking. A subsidiary brand, MEDEZE Cosmeceutical, offers skincare products utilizing growth factors from stem cells. The company's research arm (MEDEZE Research & Development) drives innovation in regenerative medicine applications including cornea production, cancer targeting, and osteoarthritis treatment. All services operate under international quality standards including ISO 9001:2015 and AABB accreditation.

Product and service3 records
1MEDEZE STEM CELL (Cord Blood, Cord Tissue, Adipose Tissue Banking)
CategoryStem Cell Banking
Description

Comprehensive stem cell banking service covering Hematopoietic Stem Cells (HSC) from cord blood, Mesenchymal Stem Cells (MSC) from placenta/cord tissue, and Mesenchymal Stem Cells (ADSC) from adipose tissue. Includes AXP AutoXpress automated isolation, closed-system sterile processing, and cryopreservation at -196°C with viability up to 60 years. Designed for expecting parents banking for newborns and adults banking for future regenerative medicine.

2MEDEZE NK (NK Cell Screening and Therapy)
CategoryImmune Cell Therapy
Description

Natural Killer (NK) Cell services including the NK Activity Test for immune capacity screening, NK Cell banking, and Highly Active NK Cell Therapy cultivated using the Osaki Method from Japan. Designed for individuals seeking immune system assessment and enhancement, cancer prevention, and viral defense. The Osaki Method maximizes NK cell potency for immunotherapy applications.

3MEDEZE HAIR RENAISSANCE (Hair Follicle Stem Cell Banking)
CategoryStem Cell Banking
Description

Proprietary hair follicle stem cell banking service that preserves hair follicle cells for future hair restoration treatments. Requires only approximately 50 hair follicles for extraction (compared to ~3,000 required by traditional hair transplant methods), performed by specialized physicians with laboratory-grade cryopreservation. Designed for individuals interested in innovative, minimally invasive alternatives to traditional hair transplant procedures.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1Thailand Ministry of Public Health (ATMPs Sandbox)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

MEDEZE is the sole private sector participant in Thailand's ATMPs Sandbox program, a regulatory sandbox initiative by the Ministry of Public Health for developing advanced cell therapies. Pilot sites include Bangrak Medical Center (Bangkok) and Vachira Phuket Hospital, focusing on Stem Cell Therapy and NK Cell Immunotherapy for 4 disease areas (osteoarthritis, anti-aging, degenerative disc disease, skin rejuvenation).

prnewswire.co.uk
2Dr. Junichi Masuyama / New City Osaki Clinic, Japan
Strategic tierCoreTypeStrategic or Co-development Partner
Description

MEDEZE partners with Dr. Junichi Masuyama, creator of the Osaki Method for Highly Active NK Cell Therapy. Dr. Masuyama serves as Advisory Board member for MEDEZE NK Cell, providing expertise in NK cell cultivation for cancer immunotherapy and immune strengthening applications.

medezegroup.com
330+ Partner Hospitals
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

MEDEZE has established partnerships with more than 30 hospitals, providing stem cell banking services and access to regenerative medicine treatments for clients referred through hospital networks.

medezegroup.com
Strategic tierModerateTypeStrategic or Co-development Partner
Description

Partnership with Suranaree University of Technology under Prof. Dr. Rangsun Parnpai, focusing on embryonic stem cell research and cloning, as well as corneal production from adipose-derived mesenchymal stem cells (animal trial stage with Chulalongkorn University Veterinary Faculty).

Strategic tierModerateTypeStrategic or Co-development Partner
Description

Collaboration with Phramongkutklao Hospital for applying stored adipose-derived stem cells in osteoarthritis treatment research.

Strategic tierModerateTypeStrategic or Co-development Partner
Description

Partnership for corneal production research from stem cells, currently in animal trial stage at Chulalongkorn University's Veterinary Faculty.

7AXP AutoXpress Platform (ThermoGenesis/Terumo)
Strategic tierCoreTypeTechnology or Integration
Description

MEDEZE uses the AXP AutoXpress Platform for automated isolation of Hematopoietic Stem Cells from cord blood, achieving up to 98.7% cell recovery rates. This automated technology reduces contamination risk and human error in the cell isolation process.

medezegroup.com
Strategic tierMinorTypeOthers
Description

Frost & Sullivan provides ongoing market recognition and industry analyst awards to MEDEZE, including Southeast Asia Company of the Year 2025 and multiple consecutive Thailand Stem Cell Banking Company of the Year awards.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-based stem cell bank offering cord blood and tissue banking services to families. Comparable to MEDEZE on DTC consumer banking model, expectant parent focus, multi-source collection, and long-term cryopreservation service offerings.

TypeDirect peer
Description

US-listed cord blood and tissue bank offering direct-to-consumer stem cell banking services. Directly comparable to MEDEZE on business model (collection, processing, long-term cryopreservation), customer segments (expectant parents and families), and recurring storage revenue, though operating in North America rather than Southeast Asia.

TypeDirect peer
Description

UK-based stem cell banking company focused on cord blood and tissue storage for families and expectant parents. Directly comparable on DTC service model, geographic multi-market presence, and core cryopreservation offerings.

TypeBroad incumbent
Description

One of the largest US cord blood banks, now part of Generate Life Sciences which offers broader reproductive and newborn services. Comparable to MEDEZE on cord blood banking, expectant parent focus, and large-scale storage operations, but operates within a wider portfolio of family/newborn services.

TypeBroad incumbent
Description

US cord blood banking service owned by Revvity (formerly PerkinElmer), a large life sciences tools company. Comparable to MEDEZE on core stem cell banking service and expectant parent customer base, but operates as a smaller unit within a much larger life sciences conglomerate with broader diagnostics and research offerings.

TypeDirect peer
Description

UK-headquartered stem cell banking company operating across multiple geographies, offering cord blood, cord tissue, and dental pulp stem cell storage. Direct peer based on multi-country DTC stem cell banking model, multi-source collection approach, and long-term cryopreservation service.

7Esperite (formerly Cryo-Save)
TypeRegional player
Description

European-headquartered family stem cell bank with operations across multiple European, Asian, and African markets. Comparable to MEDEZE on multi-country DTC stem cell banking model and recurring storage revenue, but operates in a different geographic footprint.

TypeEmerging player
Description

India-based stem cell therapy company developing allogeneic mesenchymal stem cell products for clinical use. Comparable to MEDEZE on stem cell therapy development and emerging market focus, but focused on therapeutic product development rather than consumer banking storage.

TypeOthers
Description

Germany-headquartered supplier of cell culture reagents and GMP-grade raw materials for cell and gene therapy manufacturing. Comparable to MEDEZE in the broader cell therapy ecosystem, but functions as an upstream supplier/technology enabler rather than a direct competitor in stem cell banking services.

TypeDirect peer
Description

US-headquartered umbilical cord blood bank with global operations across Asia (including India, Taiwan). Directly comparable to MEDEZE on cord blood banking model, multi-country Asian presence, and treatment-application positioning for hematopoietic and regenerative uses.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medeze Group

Stem Cell Banking Servicesmedezegroup.com

Medeze Group is a Thailand-based stem cell banking and regenerative medicine company that collects, isolates, cryopreserves, and cultivates mesenchymal, hematopoietic, adipose-derived, and hair follicle stem cells, plus NK cell immune services, serving individual consumers across six Southeast Asian countries.

Medeze Group firmographics

Firmographics
Name
Medeze Group
Legal name
MEDEZE Group Public Company Limited (บริษัท เมดีซ กรุ๊ป จำกัด (มหาชน))
Website
https://medezegroup.com
Company type
Public
Founded year
2010
Operating status
Operating
Headcount range
51–100 employees
Short description
Medeze Group is a Thailand-based stem cell banking and regenerative medicine company that collects, isolates, cryopreserves, and cultivates mesenchymal, hematopoietic, adipose-derived, and hair follicle stem cells, plus NK cell immune services, serving individual consumers across six Southeast Asian countries.
Ownership category
akta.pro rank

Medeze Group industry classification

Industry
Product category
Stem Cell Banking Services
NAICS
Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAAGAA
Stem Cell–Based Regenerative Therapies
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAABAE
Stem Cell Therapies (MSC/iPSC/HSC-derived)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAABAD
NK Cell Therapies
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)

Keywords

  • Stem cell banking
  • Regenerative medicine
  • Cord blood banking
  • NK cell therapy
  • Cryopreservation services

Where Medeze Group is headquartered

Location

Headquarters

HQ city
Bangkok
HQ country
Thailand
HQ region
Asia

Offices6 records

Markets served

Medeze Group business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Stem Cell Banking Services: One-time collection and long-term storage fees for stem cells from cord blood, cord tissue, and adipose tissue. Services are priced as packages starting from 69,000 THB for cord blood banking. Revenue is generated through upfront collection/processing fees combined with ongoing storage fees over the contracted storage period.
  2. NK Cell Services: NK Cell screening (NK Test) and NK Cell banking with cultivation using the Osaki Method. These services provide immune capacity assessment and highly active NK cell therapy for cancer prevention and immune strengthening.
  3. Hair Follicle Cell Banking: Hair follicle stem cell banking service using proprietary extraction and cryopreservation technology, a niche offering requiring minimal hair follicle extraction compared to traditional methods.
  4. Medical Wellness Services: Regenerative medicine and anti-aging services including precision medicine consultations, ATMPs Sandbox clinical programs, and longevity-focused healthcare solutions positioned for commercialization by 2026.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goCord Blood Stem Cell Banking - starting price
One time/ perpetual licensePay-as-you-goAdipose Tissue Stem Cell Banking - starting price
One time/ perpetual licensePay-as-you-goAdipose Tissue Stem Cell Banking (C-Section) - starting price
One time/ perpetual licensePay-as-you-goCord Tissue Stem Cell Banking

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Medeze Group product offering

Product offering

Core offering

Medeze Group provides stem cell banking services collecting, isolating, and cryopreserving stem cells from cord blood, cord tissue, adipose tissue, and hair follicles for newborns and adults. The company also offers NK Cell immune screening and Highly Active NK Cell therapy (Osaki Method), as well as hair follicle stem cell banking under the Medeze Hair Renaissance brand. All services operate under ISO 9001:2015 and AABB international accreditation standards from the Thailand headquarters.

Product overview

MEDEZE Group is a healthcare company offering a portfolio of stem cell banking and regenerative medicine services. The core offering is MEDEZE STEM CELL, which provides multiple stem cell banking services from various sources (cord blood, cord tissue, adipose tissue, and hair follicles) for both newborns and adults. This is complemented by MEDEZE NK for immune cell services (NK Test screening and Osaki Method-based cultivation), and MEDEZE HAIR RENAISSANCE for specialized hair follicle stem cell banking. A subsidiary brand, MEDEZE Cosmeceutical, offers skincare products utilizing growth factors from stem cells. The company's research arm (MEDEZE Research & Development) drives innovation in regenerative medicine applications including cornea production, cancer targeting, and osteoarthritis treatment. All services operate under international quality standards including ISO 9001:2015 and AABB accreditation.

Differentiator

Problem solved

Functional benefit

Brands

  • MEDEZE STEM CELL: Stem cell banking services covering cord blood, cord tissue, adipose tissue, and hair follicle stem cell collection, isolation, and cryopreservation.
  • MEDEZE NK
  • MEDEZE Hair Renaissance

Products and services

  • MEDEZE STEM CELL (Cord Blood, Cord Tissue, Adipose Tissue Banking) Comprehensive stem cell banking service covering Hematopoietic Stem Cells (HSC) from cord blood, Mesenchymal Stem Cells (MSC) from placenta/cord tissue, and Mesenchymal Stem Cells (ADSC) from adipose tissue. Includes AXP AutoXpress automated isolation, closed-system sterile processing, and cryopreservation at -196°C with viability up to 60 years. Designed for expecting parents banking for newborns and adults banking for future regenerative medicine.
  • MEDEZE NK (NK Cell Screening and Therapy) Natural Killer (NK) Cell services including the NK Activity Test for immune capacity screening, NK Cell banking, and Highly Active NK Cell Therapy cultivated using the Osaki Method from Japan. Designed for individuals seeking immune system assessment and enhancement, cancer prevention, and viral defense. The Osaki Method maximizes NK cell potency for immunotherapy applications.
  • MEDEZE HAIR RENAISSANCE (Hair Follicle Stem Cell Banking) Proprietary hair follicle stem cell banking service that preserves hair follicle cells for future hair restoration treatments. Requires only approximately 50 hair follicles for extraction (compared to ~3,000 required by traditional hair transplant methods), performed by specialized physicians with laboratory-grade cryopreservation. Designed for individuals interested in innovative, minimally invasive alternatives to traditional hair transplant procedures.

Quantifiable outcome

  • Up to 98.7% stem cell isolation accuracy using AXP AutoXpress Platform
  • +5 more outcomes

Companies that use Medeze Group

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Medeze Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Medeze Group partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, minor and moderate.

  • Thailand Ministry of Public Health (ATMPs Sandbox)coreStrategic or Co-development PartnerMEDEZE is the sole private sector participant in Thailand's ATMPs Sandbox program, a regulatory sandbox initiative by the Ministry of Public Health for developing advanced cell therapies. Pilot sites include Bangrak Medical Center (Bangkok) and Vachira Phuket Hospital, focusing on Stem Cell Therapy and NK Cell Immunotherapy for 4 disease areas (osteoarthritis, anti-aging, degenerative disc disease, skin rejuvenation).
  • Dr. Junichi Masuyama / New City Osaki Clinic, JapancoreStrategic or Co-development PartnerMEDEZE partners with Dr. Junichi Masuyama, creator of the Osaki Method for Highly Active NK Cell Therapy. Dr. Masuyama serves as Advisory Board member for MEDEZE NK Cell, providing expertise in NK cell cultivation for cancer immunotherapy and immune strengthening applications.
  • 30+ Partner HospitalsminorChannel Partner/ Reseller/ DistributorMEDEZE has established partnerships with more than 30 hospitals, providing stem cell banking services and access to regenerative medicine treatments for clients referred through hospital networks.
  • Suranaree University of Technology (SUT)moderateStrategic or Co-development PartnerPartnership with Suranaree University of Technology under Prof. Dr. Rangsun Parnpai, focusing on embryonic stem cell research and cloning, as well as corneal production from adipose-derived mesenchymal stem cells (animal trial stage with Chulalongkorn University Veterinary Faculty).
  • Phramongkutklao HospitalmoderateStrategic or Co-development PartnerCollaboration with Phramongkutklao Hospital for applying stored adipose-derived stem cells in osteoarthritis treatment research.
  • Chulalongkorn University Veterinary FacultymoderateStrategic or Co-development PartnerPartnership for corneal production research from stem cells, currently in animal trial stage at Chulalongkorn University's Veterinary Faculty.
  • AXP AutoXpress Platform (ThermoGenesis/Terumo)coreTechnology or IntegrationMEDEZE uses the AXP AutoXpress Platform for automated isolation of Hematopoietic Stem Cells from cord blood, achieving up to 98.7% cell recovery rates. This automated technology reduces contamination risk and human error in the cell isolation process.
  • Frost & SullivanminorOthersFrost & Sullivan provides ongoing market recognition and industry analyst awards to MEDEZE, including Southeast Asia Company of the Year 2025 and multiple consecutive Thailand Stem Cell Banking Company of the Year awards.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Medeze Group competitors and assessment

Company assessment

Direct peers

  • Cells4Life: UK-based stem cell bank offering cord blood and tissue banking services to families. Comparable to MEDEZE on DTC consumer banking model, expectant parent focus, multi-source collection, and long-term cryopreservation service offerings.
  • Cryo-Cell International: US-listed cord blood and tissue bank offering direct-to-consumer stem cell banking services. Directly comparable to MEDEZE on business model (collection, processing, long-term cryopreservation), customer segments (expectant parents and families), and recurring storage revenue, though operating in North America rather than Southeast Asia.
  • Smart Cells International: UK-based stem cell banking company focused on cord blood and tissue storage for families and expectant parents. Directly comparable on DTC service model, geographic multi-market presence, and core cryopreservation offerings.
  • Future Health Biobank: UK-headquartered stem cell banking company operating across multiple geographies, offering cord blood, cord tissue, and dental pulp stem cell storage. Direct peer based on multi-country DTC stem cell banking model, multi-source collection approach, and long-term cryopreservation service.
  • StemCyte: US-headquartered umbilical cord blood bank with global operations across Asia (including India, Taiwan). Directly comparable to MEDEZE on cord blood banking model, multi-country Asian presence, and treatment-application positioning for hematopoietic and regenerative uses.

Broad incumbents

  • Cord Blood Registry (CBR) by Generate Life Sciences: One of the largest US cord blood banks, now part of Generate Life Sciences which offers broader reproductive and newborn services. Comparable to MEDEZE on cord blood banking, expectant parent focus, and large-scale storage operations, but operates within a wider portfolio of family/newborn services.
  • ViaCord (Revvity): US cord blood banking service owned by Revvity (formerly PerkinElmer), a large life sciences tools company. Comparable to MEDEZE on core stem cell banking service and expectant parent customer base, but operates as a smaller unit within a much larger life sciences conglomerate with broader diagnostics and research offerings.

Regional players

  • Esperite (formerly Cryo-Save): European-headquartered family stem cell bank with operations across multiple European, Asian, and African markets. Comparable to MEDEZE on multi-country DTC stem cell banking model and recurring storage revenue, but operates in a different geographic footprint.

Emerging players

  • Stempeutics Research: India-based stem cell therapy company developing allogeneic mesenchymal stem cell products for clinical use. Comparable to MEDEZE on stem cell therapy development and emerging market focus, but focused on therapeutic product development rather than consumer banking storage.

Others

  • CellGenix: Germany-headquartered supplier of cell culture reagents and GMP-grade raw materials for cell and gene therapy manufacturing. Comparable to MEDEZE in the broader cell therapy ecosystem, but functions as an upstream supplier/technology enabler rather than a direct competitor in stem cell banking services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Medeze Group social profiles

Digital presence

Medeze Group compliance and trust

Trust signal

Compliance4 records

Medeze Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medeze Group leadership team

Management profile

Number of profiles

Profiles11 records

Medeze Group subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Medeze Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medeze Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medeze Group

What does Medeze Group do?

Medeze Group provides stem cell banking services collecting, isolating, and cryopreserving stem cells from cord blood, cord tissue, adipose tissue, and hair follicles for newborns and adults. The company also offers NK Cell immune screening and Highly Active NK Cell therapy (Osaki Method), as well as hair follicle stem cell banking under the Medeze Hair Renaissance brand. All services operate under ISO 9001:2015 and AABB international accreditation standards from the Thailand headquarters.

Is Medeze Group a public or private company?

Medeze Group is a public company. It is classified as unknown and is currently operating.

When was Medeze Group founded?

Medeze Group was founded in 2010. It employs 51 to 100 people.

Where is Medeze Group based?

Medeze Group is headquartered in Bangkok, Thailand, in the Asia region.

How does Medeze Group make money?

Four revenue lines are on record. Stem Cell Banking Services are the primary driver. The others are NK Cell Services, hair Follicle Cell Banking and medical Wellness Services.

Who are Medeze Group's main competitors?

Direct peers on record are Cells4Life, Cryo-Cell International, Smart Cells International, Future Health Biobank and StemCyte. Broad incumbents are Cord Blood Registry (CBR) by Generate Life Sciences and ViaCord (Revvity). Esperite (formerly Cryo-Save) is listed as a regional player. Stempeutics Research is listed as an emerging player. CellGenix is listed as an others.

Does Medeze Group have an API?

No public API is recorded for Medeze Group.

What industry is Medeze Group in?

Medeze Group's product category is Stem Cell Banking Services. Its primary akta.pro industry code is HLAAAGAA, Stem Cell–Based Regenerative Therapies, with a secondary code of HLAAABAE, Stem Cell Therapies (MSC/iPSC/HSC-derived). Its NAICS code is 621991 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales